About semler scientific inc - SMLR
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Campbell, CA.
SMLR At a Glance
Semler Scientific, Inc.
51 East Campbell Avenue
Campbell, California 95008
| Phone | 1-877-774-4211 | Revenue | 56.29M | |
| Industry | Medical Specialties | Net Income | 40.90M | |
| Sector | Health Technology | Employees | 79 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
SMLR Valuation
| P/E Current | 5.50 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 10.536 |
| Price to Sales Ratio | 7.655 |
| Price to Book Ratio | 2.236 |
| Price to Cash Flow Ratio | 17.65 |
| Enterprise Value to EBITDA | 19.335 |
| Enterprise Value to Sales | 7.389 |
| Total Debt to Enterprise Value | 0.00 |
SMLR Efficiency
| Revenue/Employee | 712,582.278 |
| Income Per Employee | 517,708.861 |
| Receivables Turnover | 11.581 |
| Total Asset Turnover | 0.351 |
SMLR Liquidity
| Current Ratio | 3.594 |
| Quick Ratio | 3.537 |
| Cash Ratio | 2.384 |
SMLR Profitability
| Gross Margin | 91.546 |
| Operating Margin | 37.185 |
| Pretax Margin | 85.061 |
| Net Margin | 72.653 |
| Return on Assets | 25.471 |
| Return on Equity | 27.037 |
| Return on Total Capital | 17.719 |
| Return on Invested Capital | 27.03 |
SMLR Capital Structure
| Total Debt to Total Equity | 0.03 |
| Total Debt to Total Capital | 0.03 |
| Total Debt to Total Assets | 0.029 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |